AGO Recommendations for Diagnosis and Treatment of Patients with Early and Metastatic Breast Cancer: Update 2012 [PDF]
Harbeck, Nadia +2 more
core +2 more sources
Development and Validation of Nomogram Predicting Survival in Resectable Gallbladder Cancer
ABSTRACT Background Gallbladder cancers (GBCs) are aggressive tumors with limited improvement in outcomes over decades. Accurate prediction of survival is crucial for tailored treatment and improved outcomes. Objective To develop a nomogram predicting overall survival (OS) in resectable GBCs.
Shraddha Patkar +9 more
wiley +1 more source
Recurrent laryngeal nerve lymph nodes status prediction after neoadjuvant therapy for thoracic esophageal squamous cell carcinoma. [PDF]
Wu F +11 more
europepmc +1 more source
ABSTRACT Background Gallbladder cancer (GBC) is an aggressive malignancy in which lymph node (LN) status is a key prognostic factor. Adequate LN retrieval is essential for accurate nodal staging. This study aimed to identify an LN threshold that reduces false node‐negative (false N0) rates and to evaluate its association with overall survival (OS) as ...
So Jeong Yoon +9 more
wiley +1 more source
The role of neoadjuvant therapy in elderly patients with T1b-T2N + esophageal cancer: a population-based cohort study. [PDF]
Lin JP +6 more
europepmc +1 more source
Postoperative Weight Gain, Due to Fluid Retention After Ovarian Cancer Surgery—How Much Is too Much?
ABSTRACT Background and Objectives Postoperative complications after cytoreductive surgery in ovarian cancer patients are associated with impaired survival. Here, we investigated the association between postoperative weight gain due to fluid retention and the development of complications and anastomotic leakage (AL).
Eva K. Egger +7 more
wiley +1 more source
The effect of neoadjuvant therapy on radiological, surgical, and pathological results in nonmetastatic breast cancer: A retrospective observational study. [PDF]
Çorapli M, Alakuş H.
europepmc +1 more source
ABSTRACT Background The peritoneum is the third most prevalent location for metastases of colorectal cancer. In patients with resectable disease, cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC) is the preferred treatment in the Netherlands, achieving median overall survival (OS) of 36–42 months. However, during
Teun van den Heuvel +6 more
wiley +1 more source
Research trends in neoadjuvant therapy for esophageal cancer: a bibliometric and meta-analysis. [PDF]
Wang H, Zhang J, Yang J, Chang H.
europepmc +1 more source
ABSTRACT Background and Objectives This study aimed to evaluate the ability of perioperative inflammatory markers to discriminate postoperative complications within 6 months in patients with ovarian cancer–related peritoneal metastasis undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Donmez Mustafa +6 more
wiley +1 more source

